Search Results

Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction.

• Authors : Rhim, Jay Won; Eom, Youngsub; Yoon, Eun Gyu

Subjects: MEIBOMIAN glands; DRY eye syndromes; CYCLOSPORINE

• Source: Japanese Journal of Ophthalmology; May2022, Vol. 66 Issue 3, p254-263, 10p

Record details

Chitosan nanoparticles for ocular delivery of cyclosporine A.

• Authors : Başaran, Ebru (AUTHOR); Yenilmez, Evrim (AUTHOR); Berkman, Murat Sami (AUTHOR)

Subjects: CYCLOSPORINE; NANOPARTICLES; CHITOSAN

• Source: Journal of Microencapsulation. Feb2014, Vol. 31 Issue 1, p49-57. 9p.

Record details

Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery.

• Authors : Başaran, Ebru (AUTHOR); Demirel, Müzeyyen (AUTHOR); Sırmagül, Başar (AUTHOR)

Subjects: CYCLOSPORINE; CYCLIC peptides; NANOPARTICLES

• Source: Journal of Microencapsulation. Feb2010, Vol. 27 Issue 1, p37-47. 11p. 2 Charts, 8 Graphs.

Record details

The role and treatment of inflammation in dry eye disease.

• Authors : Yagci, Ayse; Gurdal, Canan

• Source: International Ophthalmology; Dec2014, Vol. 34 Issue 6, p1291-1301, 11p

Record details

New Agents for Treating Dry Eye Syndrome.

• Authors : Skalicky, Simon; Petsoglou, Con; Gurbaxani, Avinash

• Source: Current Allergy & Asthma Reports; Jun2013, Vol. 13 Issue 3, p322-328, 7p

Record details

Clinical Review: Topical Ophthalmic Use of Cyclosporin A.

• Authors : Utine, Canan Asli; Stern, Michael; Akpek, Esen K.

Subjects: CYCLOSPORINE; IMMUNOSUPPRESSIVE agents; CYCLIC peptides

• Source: Ocular Immunology & Inflammation; Oct2010, Vol. 18 Issue 5, p352-361, 10p

Record details